FIELD: medicine, cardiology. SUBSTANCE: invention relates to pharmacotherapy of pathology of cardiovascular system, in part, the novel anti-ischemic agent that shows anticalcium effect. Invention proposes the novel drug dimancal showing high antagonistic activity for calcium ions. EFFECT: broadened arsenal of agents, decreased cost, safety, enhanced anti-ischemic effect as compared with that of known analogs. 7 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICAMENT WITH PROLONGED ANTI-CALCIUM ACTIVITY IN THE FORM OF 1/10% INTRAVENOUS SOLUTION | 2004 |
|
RU2255728C1 |
| METHOD OF PREPARING DIUMANCAL-FORTE TABLETS IN DOSE 0,01 G | 2000 |
|
RU2187303C2 |
| DERIVATIVES OF 2-H-1-BENZOPYRANE-2-ONE ELICITING ANTI-CALCIUM ACTIVITY | 2003 |
|
RU2242471C1 |
| 2-[2-(DIETHYLAMINO) -ETHYLTHIO]-5,6- DIMETHYLBENZIMIDAZOLE SALTS SHOWING ANTIISCHEMIC, ANTIHYPOXIC AND ANTIARRHYTHMIC ACTIVITY AND 2-[2-(DIETHYLAMINO) -ETHYLTHIO]-5,6- DIMETHYLBENZIMIDAZOLE AS AN INTERMEDIATE PRODUCT FOR SYNTHESIS OF 2-[2-(DIETHYLAMINO) -ETHYLTHIO] -5,6-DIMETHYLBENZIMIDAZOLE SALTS | 1991 |
|
RU2027709C1 |
| ANTIARRHYTHMIC MEDICATION BASED ON 4-METHYL-7,7'-ETHYLENEDIOXY-2H-1-DIBENZOPYRAN-2,2'-DIONE | 2010 |
|
RU2427368C1 |
| ANTIARRHYTHMIC DRUG BASED ON HYBRID MOLECULES OF AMLODIPINE WITH (7-METHOXICUMARIN-4-YL)ACETIC ACID | 2018 |
|
RU2678969C1 |
| ANTICOAGULANT AGENT OF INDIRECT ACTION ON BASIS OF DIUMANCAL | 2018 |
|
RU2671983C9 |
| 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES SHOWING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND ANTIFIBRILLATORY ACTIVITY | 1995 |
|
RU2136667C1 |
| AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
| METHOD FOR DIAGNOSING OPENING OF THE CORONARY ARTERY IN ACUTE MYOCARDIAL INFARCTION PATIENTS | 1999 |
|
RU2189173C2 |
